Loading...

Abcam plc

ABCZF•PNK
Healthcare
Biotechnology
$22.25
$0.15(0.68%)

Abcam plc (ABCZF) Stock Overview

Explore Abcam plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.9/100

Key Financials

Market Cap5.1B
P/E Ratio-445.60
EPS (TTM)$0.01
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$37.05

ABCZF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abcam plc (ABCZF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $37.05.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -445.60 and a market capitalization of 5.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;